Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2016 | 09-2015 | 09-2014 | 09-2013 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,558 | -2,628 | -80 | -3,208 | 1,698 |
| Depreciation Amortization | 285 | N/A | N/A | 6 | 7 |
| Accounts receivable | 835 | -26 | -1,189 | 411 | 896 |
| Other Working Capital | 23 | 5 | -232 | -1,139 | 917 |
| Other Operating Activity | -694 | 206 | 1,824 | 960 | -4,397 |
| Operating Cash Flow | $-3,109 | $-2,443 | $323 | $-2,970 | $-879 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,000 | N/A | N/A | N/A |
| Common Stock Issued | 2,005 | 20 | 325 | 3,616 | 660 |
| Other Financing Activity | 4,165 | 0 | 0 | -58 | -18 |
| Financing Cash Flow | $6,170 | $1,020 | $325 | $3,558 | $642 |
| Beginning Cash Position | 94 | 1,517 | 869 | 281 | 518 |
| End Cash Position | 3,155 | 94 | 1,517 | 869 | 281 |
| Net Cash Flow | $3,061 | $-1,423 | $648 | $588 | $-237 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,109 | -2,443 | 323 | -2,970 | -879 |
| Free Cash Flow | -3,109 | -2,443 | 323 | -2,970 | -879 |